Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron
A pharmaceutical composition comprising 250-20,000 U of an EPO preparation
and 5-20 mg of a Fe(III) complex is disclosed. This pharmaceutical
composition is useful in treating anaemias as well or as haemodialysis
patients.